Literature DB >> 32948461

Evaluation of naloxone furnishing community pharmacies in San Francisco.

Andy M Nguyen, Thomas E Kearney, Dorie E Apollonio.   

Abstract

OBJECTIVES: In 2017, the Centers for Disease Control and Prevention reported more than 47,600 deaths as a result of opioid overdose in the United States. In an effort to reduce these deaths, California passed legislation providing pharmacists with the ability to furnish naloxone without a prescription. Our study examined pharmacies in San Francisco that furnished naloxone and provided guidance for pharmacies seeking to develop similar programs. The study aims were to (1) identify the legal, structural, social-environmental, and financial components of a pharmacy model that allows for successful naloxone distribution, (2) evaluate the attitudes and beliefs of pharmacy staff members toward patients receiving or requesting naloxone, and (3) assess relationships between these attitudes and beliefs and naloxone furnishing at the pharmacy.
METHODS: This cross-sectional study used a series of semistructured interviews of pharmacy staff in San Francisco conducted April-October 2019. Through a thematic, inductive analysis of collected data, emerging themes were mapped to the primary study aims.
RESULTS: We interviewed 14 pharmacists and pharmacy technicians at 4 community pharmacies. We identified 4 factors for success in implementing a naloxone furnishing protocol: administrative-led efforts, pharmacist-led efforts, increasing pharmacist engagement, and increasing patient engagement. The respondents also discussed the approaches they used to overcome previously identified barriers: cost, time, expectations of unwanted clientele, and patients' feelings of stigma.
CONCLUSION: Pharmacists' approaches to implementing naloxone furnishing had common features across locations, suggesting many of these strategies could be replicated in other community pharmacies.
Copyright © 2020 American Pharmacists Association®. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32948461      PMCID: PMC7655520          DOI: 10.1016/j.japh.2020.08.032

Source DB:  PubMed          Journal:  J Am Pharm Assoc (2003)        ISSN: 1086-5802


  17 in total

1.  Assessment of provider attitudes toward #naloxone on Twitter.

Authors:  Nancy A Haug; Jennifer Bielenberg; Steven H Linder; Anna Lembke
Journal:  Subst Abus       Date:  2016       Impact factor: 3.716

Review 2.  Ethnography in qualitative educational research: AMEE Guide No. 80.

Authors:  Scott Reeves; Jennifer Peller; Joanne Goldman; Simon Kitto
Journal:  Med Teach       Date:  2013-06-28       Impact factor: 3.650

Review 3.  Pharmacist roles, training, and perceived barriers in naloxone dispensing: A systematic review.

Authors:  Tanvee Thakur; Meredith Frey; Betty Chewning
Journal:  J Am Pharm Assoc (2003)       Date:  2019-07-29

4.  Perpetuating stigma or reducing risk? Perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.

Authors:  Traci C Green; Patricia Case; Haley Fiske; Janette Baird; Shachan Cabral; Dina Burstein; Victoriana Schwartz; Nathan Potter; Alexander Y Walley; Jeffrey Bratberg
Journal:  J Am Pharm Assoc (2003)       Date:  2017-02-14

5.  Pharmacists' role in opioid overdose: Kentucky pharmacists' willingness to participate in naloxone dispensing.

Authors:  Patricia R Freeman; Amie Goodin; SuZanne Troske; Audra Strahl; Amanda Fallin; Traci C Green
Journal:  J Am Pharm Assoc (2003)       Date:  2017-01-28

6.  Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.

Authors:  M Singer; H A Baer; G Scott; S Horowitz; B Weinstein
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

7.  Opioid-overdose laws association with opioid use and overdose mortality.

Authors:  Chandler McClellan; Barrot H Lambdin; Mir M Ali; Ryan Mutter; Corey S Davis; Eliza Wheeler; Michael Pemberton; Alex H Kral
Journal:  Addict Behav       Date:  2018-03-19       Impact factor: 3.913

8.  The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.

Authors:  Nickolas D Zaller; Michael A Yokell; Traci Craig Green; Julia Gaggin; Patricia Case
Journal:  Subst Use Misuse       Date:  2013-06-10       Impact factor: 2.164

9.  Dispensing Naloxone Without a Prescription: Survey Evaluation of Ohio Pharmacists.

Authors:  Erin L Thompson; P S S Rao; Christopher Hayes; Catherine Purtill
Journal:  J Pharm Pract       Date:  2018-02-25

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586

View more
  1 in total

Review 1.  Perspectives of Stakeholders of Equitable Access to Community Naloxone Programs: A Literature Review.

Authors:  Lucas Martignetti; Winnie Sun
Journal:  Cureus       Date:  2022-01-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.